

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | sarcomere organization (GO:0045214) | 5.60519388 |
| 2 | cardiac myofibril assembly (GO:0055003) | 5.42981198 |
| 3 | actin-myosin filament sliding (GO:0033275) | 5.38412550 |
| 4 | muscle filament sliding (GO:0030049) | 5.38412550 |
| 5 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 5.33114834 |
| 6 | myofibril assembly (GO:0030239) | 5.25415765 |
| 7 | axon ensheathment in central nervous system (GO:0032291) | 4.90770767 |
| 8 | central nervous system myelination (GO:0022010) | 4.90770767 |
| 9 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 4.85795425 |
| 10 | regulation of skeletal muscle contraction (GO:0014819) | 4.80064298 |
| 11 | actin-mediated cell contraction (GO:0070252) | 4.70816106 |
| 12 | regulation of relaxation of muscle (GO:1901077) | 4.62516057 |
| 13 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 4.59216754 |
| 14 | negative regulation of protein localization to cell surface (GO:2000009) | 4.59216348 |
| 15 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 4.58698505 |
| 16 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 4.55796989 |
| 17 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 4.53444060 |
| 18 | regulation of actin filament-based movement (GO:1903115) | 4.50148340 |
| 19 | regulation of cell communication by electrical coupling (GO:0010649) | 4.35691711 |
| 20 | response to muscle activity (GO:0014850) | 4.26950827 |
| 21 | creatine metabolic process (GO:0006600) | 4.26145816 |
| 22 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 4.18701920 |
| 23 | cardiac muscle contraction (GO:0060048) | 4.16004190 |
| 24 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 4.14879722 |
| 25 | regulation of sarcomere organization (GO:0060297) | 4.06614078 |
| 26 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 4.00700026 |
| 27 | adult heart development (GO:0007512) | 3.96686069 |
| 28 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 3.96020705 |
| 29 | myotube cell development (GO:0014904) | 3.95997120 |
| 30 | skeletal muscle fiber development (GO:0048741) | 3.90665774 |
| 31 | actomyosin structure organization (GO:0031032) | 3.88007804 |
| 32 | muscle fiber development (GO:0048747) | 3.81417021 |
| 33 | cardiac muscle tissue morphogenesis (GO:0055008) | 3.81201318 |
| 34 | regulation of striated muscle contraction (GO:0006942) | 3.74769828 |
| 35 | striated muscle contraction (GO:0006941) | 3.74244987 |
| 36 | plasma membrane repair (GO:0001778) | 3.71991663 |
| 37 | ventricular cardiac muscle cell action potential (GO:0086005) | 3.71170830 |
| 38 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 3.69040711 |
| 39 | cardiac muscle hypertrophy (GO:0003300) | 3.68417978 |
| 40 | cardiac muscle cell development (GO:0055013) | 3.68086295 |
| 41 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 3.66541755 |
| 42 | striated muscle hypertrophy (GO:0014897) | 3.56716015 |
| 43 | actin filament-based movement (GO:0030048) | 3.56019908 |
| 44 | muscle tissue morphogenesis (GO:0060415) | 3.54121041 |
| 45 | ventricular cardiac muscle tissue morphogenesis (GO:0055010) | 3.49355336 |
| 46 | regulation of membrane repolarization (GO:0060306) | 3.48450820 |
| 47 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 3.46067139 |
| 48 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 3.45609920 |
| 49 | cardiac cell development (GO:0055006) | 3.45513585 |
| 50 | fatty acid elongation (GO:0030497) | 3.42791091 |
| 51 | regulation of cardiac muscle cell contraction (GO:0086004) | 3.42101188 |
| 52 | carnitine shuttle (GO:0006853) | 3.39862128 |
| 53 | muscle cell cellular homeostasis (GO:0046716) | 3.35475899 |
| 54 | response to inactivity (GO:0014854) | 3.32577928 |
| 55 | striated muscle cell development (GO:0055002) | 3.32241618 |
| 56 | myelination (GO:0042552) | 3.29907480 |
| 57 | axon ensheathment (GO:0008366) | 3.27576269 |
| 58 | ensheathment of neurons (GO:0007272) | 3.27576269 |
| 59 | cell communication involved in cardiac conduction (GO:0086065) | 3.24971083 |
| 60 | regulation of cardiac muscle contraction (GO:0055117) | 3.24741429 |
| 61 | skeletal muscle contraction (GO:0003009) | 3.24111093 |
| 62 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 3.15434391 |
| 63 | response to epinephrine (GO:0071871) | 3.13377856 |
| 64 | heart trabecula formation (GO:0060347) | 3.10697958 |
| 65 | skeletal muscle tissue development (GO:0007519) | 3.10109302 |
| 66 | cellular response to epinephrine stimulus (GO:0071872) | 3.08696412 |
| 67 | tricarboxylic acid cycle (GO:0006099) | 3.07172200 |
| 68 | otic vesicle formation (GO:0030916) | 3.04523706 |
| 69 | muscle hypertrophy (GO:0014896) | 3.03297693 |
| 70 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.02585420 |
| 71 | myoblast fusion (GO:0007520) | 3.00280706 |
| 72 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 3.00256815 |
| 73 | skeletal muscle adaptation (GO:0043501) | 2.99608731 |
| 74 | respiratory electron transport chain (GO:0022904) | 2.93580965 |
| 75 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 2.93130811 |
| 76 | heart process (GO:0003015) | 2.92100681 |
| 77 | heart contraction (GO:0060047) | 2.92100681 |
| 78 | myotube differentiation (GO:0014902) | 2.87373538 |
| 79 | muscle organ development (GO:0007517) | 2.87011792 |
| 80 | fatty acid transmembrane transport (GO:1902001) | 2.84871805 |
| 81 | desmosome organization (GO:0002934) | 2.84602324 |
| 82 | muscle cell development (GO:0055001) | 2.84510328 |
| 83 | cardiac muscle cell action potential (GO:0086001) | 2.84340612 |
| 84 | electron transport chain (GO:0022900) | 2.83646827 |
| 85 | * muscle structure development (GO:0061061) | 2.82897784 |
| 86 | regulation of cardioblast differentiation (GO:0051890) | 2.81947780 |
| 87 | regulation of calcium ion transmembrane transporter activity (GO:1901019) | 2.81937358 |
| 88 | regulation of calcium ion transmembrane transport (GO:1903169) | 2.81937358 |
| 89 | striated muscle adaptation (GO:0014888) | 2.80321998 |
| 90 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 2.77668041 |
| 91 | cardiac muscle cell action potential involved in contraction (GO:0086002) | 2.76928372 |
| 92 | detection of calcium ion (GO:0005513) | 2.76116195 |
| 93 | muscle contraction (GO:0006936) | 2.75936291 |
| 94 | pyrimidine nucleobase catabolic process (GO:0006208) | 2.75808076 |
| 95 | negative regulation of calcium ion transmembrane transporter activity (GO:1901020) | 2.75645199 |
| 96 | negative regulation of calcium ion transmembrane transport (GO:1903170) | 2.75645199 |
| 97 | regulation of potassium ion transmembrane transporter activity (GO:1901016) | 2.74884369 |
| 98 | cardiac conduction (GO:0061337) | 2.72617511 |
| 99 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 2.72523739 |
| 100 | regulation of heart rate (GO:0002027) | 2.70995735 |
| 101 | relaxation of cardiac muscle (GO:0055119) | 2.70356112 |
| 102 | regulation of the force of heart contraction (GO:0002026) | 2.69253893 |
| 103 | muscle cell fate commitment (GO:0042693) | 2.68367143 |
| 104 | cell communication by electrical coupling (GO:0010644) | 2.67287221 |
| 105 | regulation of cofactor metabolic process (GO:0051193) | 2.66637453 |
| 106 | regulation of coenzyme metabolic process (GO:0051196) | 2.66637453 |
| 107 | positive regulation of action potential (GO:0045760) | 2.66583756 |
| 108 | skeletal muscle tissue regeneration (GO:0043403) | 2.66581139 |
| 109 | myelination in peripheral nervous system (GO:0022011) | 2.66347589 |
| 110 | peripheral nervous system axon ensheathment (GO:0032292) | 2.66347589 |
| 111 | neuromuscular synaptic transmission (GO:0007274) | 2.66154865 |
| 112 | positive regulation of sodium ion transmembrane transport (GO:1902307) | 2.64499830 |
| 113 | neuronal action potential propagation (GO:0019227) | 2.63379643 |
| 114 | carnitine transmembrane transport (GO:1902603) | 2.63258665 |
| 115 | regulation of heart rate by cardiac conduction (GO:0086091) | 2.63183679 |
| 116 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 2.62730505 |
| 117 | positive regulation of cardiac muscle cell differentiation (GO:2000727) | 2.62644491 |
| 118 | glycogen catabolic process (GO:0005980) | 2.62639209 |
| 119 | glucan biosynthetic process (GO:0009250) | 2.56546786 |
| 120 | glycogen biosynthetic process (GO:0005978) | 2.56546786 |
| 121 | muscle system process (GO:0003012) | 2.54867562 |
| 122 | ATP synthesis coupled proton transport (GO:0015986) | 2.54221141 |
| 123 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 2.54221141 |
| 124 | positive regulation of cation channel activity (GO:2001259) | 2.53458617 |
| 125 | regulation of skeletal muscle cell differentiation (GO:2001014) | 2.52685214 |
| 126 | cardiac muscle adaptation (GO:0014887) | 2.50550926 |
| 127 | cardiac muscle hypertrophy in response to stress (GO:0014898) | 2.50550926 |
| 128 | muscle hypertrophy in response to stress (GO:0003299) | 2.50550926 |
| 129 | amino-acid betaine transport (GO:0015838) | 2.50375896 |
| 130 | carnitine transport (GO:0015879) | 2.50375896 |
| 131 | regulation of heart contraction (GO:0008016) | 2.49816772 |
| 132 | relaxation of muscle (GO:0090075) | 2.48664958 |
| 133 | regulation of sequestering of triglyceride (GO:0010889) | 2.48563991 |
| 134 | striated muscle tissue development (GO:0014706) | 2.46209729 |
| 135 | regulation of muscle system process (GO:0090257) | 2.46014304 |
| 136 | postsynaptic membrane organization (GO:0001941) | 2.44886869 |
| 137 | syncytium formation by plasma membrane fusion (GO:0000768) | 2.43345204 |
| 138 | positive regulation of ion transmembrane transporter activity (GO:0032414) | 2.39453121 |
| 139 | cardiac chamber formation (GO:0003207) | 2.38432397 |
| 140 | cardiac ventricle formation (GO:0003211) | 2.37611073 |
| 141 | glucan catabolic process (GO:0009251) | 2.36268727 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 3.35473618 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 2.99417534 |
| 3 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 2.60598118 |
| 4 | IGF1R_20145208_ChIP-Seq_DFB_Human | 2.42030468 |
| 5 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.40945060 |
| 6 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 2.36105512 |
| 7 | SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.23701161 |
| 8 | SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.10214565 |
| 9 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.08702060 |
| 10 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 2.08692961 |
| 11 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.03292516 |
| 12 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 1.95427957 |
| 13 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.91883603 |
| 14 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 1.89976538 |
| 15 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 1.89976538 |
| 16 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.82887766 |
| 17 | * SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.79499768 |
| 18 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 1.76759939 |
| 19 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.75161212 |
| 20 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.74929681 |
| 21 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.71929156 |
| 22 | SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 1.71682227 |
| 23 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 1.70843219 |
| 24 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.64136914 |
| 25 | * ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.61769551 |
| 26 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.61678936 |
| 27 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 1.61636134 |
| 28 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.60592056 |
| 29 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.59489567 |
| 30 | SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 1.58450832 |
| 31 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.54277488 |
| 32 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.51941294 |
| 33 | SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.51152708 |
| 34 | RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.49831428 |
| 35 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.48143989 |
| 36 | * OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.46852056 |
| 37 | SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.45997140 |
| 38 | * TAF15_26573619_Chip-Seq_HEK293_Human | 1.43598909 |
| 39 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.40604443 |
| 40 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.38519357 |
| 41 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.38460494 |
| 42 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.36843628 |
| 43 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.36843628 |
| 44 | VDR_22108803_ChIP-Seq_LS180_Human | 1.36297930 |
| 45 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.35554704 |
| 46 | * TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.35554140 |
| 47 | * TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.35554140 |
| 48 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.34680776 |
| 49 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.34178434 |
| 50 | HOXD13_18407260_ChIP-ChIP_DEVELOPING-LIMBS_Mouse | 1.33090691 |
| 51 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.33054622 |
| 52 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.32144517 |
| 53 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.31090860 |
| 54 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.30850281 |
| 55 | EWS_26573619_Chip-Seq_HEK293_Human | 1.30402352 |
| 56 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.30182316 |
| 57 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.28848619 |
| 58 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.28396687 |
| 59 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.28055583 |
| 60 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.27561718 |
| 61 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.27316835 |
| 62 | P300_19829295_ChIP-Seq_ESCs_Human | 1.26339246 |
| 63 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.24976317 |
| 64 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.23721755 |
| 65 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 1.23278703 |
| 66 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.23236877 |
| 67 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.22137539 |
| 68 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.20778014 |
| 69 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.20716817 |
| 70 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.20716817 |
| 71 | KLF5_20875108_ChIP-Seq_MESCs_Mouse | 1.20533528 |
| 72 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 1.19729999 |
| 73 | FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.19672381 |
| 74 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.18455897 |
| 75 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.17943752 |
| 76 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.17333954 |
| 77 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 1.16959517 |
| 78 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.16487566 |
| 79 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.15540343 |
| 80 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.11906316 |
| 81 | * NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.11602888 |
| 82 | * TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.11342628 |
| 83 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.11049317 |
| 84 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.10794736 |
| 85 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 1.10632986 |
| 86 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.10619556 |
| 87 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.10006355 |
| 88 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.09909577 |
| 89 | KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 1.09724297 |
| 90 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.08475412 |
| 91 | STAT3_23295773_ChIP-Seq_U87_Human | 1.08269646 |
| 92 | FUS_26573619_Chip-Seq_HEK293_Human | 1.07583054 |
| 93 | * P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.07446306 |
| 94 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.06932844 |
| 95 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 1.06863550 |
| 96 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 1.06810145 |
| 97 | SOX9_26525672_Chip-Seq_HEART_Mouse | 1.06670049 |
| 98 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 1.06605001 |
| 99 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.06418574 |
| 100 | * CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.05978226 |
| 101 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.05384560 |
| 102 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.05244122 |
| 103 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.05109009 |
| 104 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.03410570 |
| 105 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.02151618 |
| 106 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 1.02102558 |
| 107 | * ISL1_27105846_Chip-Seq_CPCs_Mouse | 1.02051667 |
| 108 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.01876479 |
| 109 | BCAT_22108803_ChIP-Seq_LS180_Human | 1.01073931 |
| 110 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.00415261 |
| 111 | * TCF4_23295773_ChIP-Seq_U87_Human | 0.99922142 |
| 112 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 0.98217522 |
| 113 | TP53_18474530_ChIP-ChIP_U2OS_Human | 0.97944016 |
| 114 | TP53_16413492_ChIP-PET_HCT116_Human | 0.97458964 |
| 115 | * LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.96473948 |
| 116 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 0.96387455 |
| 117 | TBL1_22424771_ChIP-Seq_293T_Human | 0.94480607 |
| 118 | AR_25329375_ChIP-Seq_VCAP_Human | 0.93230165 |
| 119 | * TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.92874015 |
| 120 | CJUN_26792858_Chip-Seq_BT549_Human | 0.92371740 |
| 121 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 0.91412269 |
| 122 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.91338502 |
| 123 | * VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 0.90899095 |
| 124 | TAL1_26923725_Chip-Seq_HPCs_Mouse | 0.90877570 |
| 125 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 0.90815370 |
| 126 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 0.89901119 |
| 127 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 0.89864383 |
| 128 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.89864383 |
| 129 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 0.89222886 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002837_dystrophic_cardiac_calcinosis | 4.61118371 |
| 2 | MP0000751_myopathy | 4.42209990 |
| 3 | MP0004084_abnormal_cardiac_muscle | 3.96257051 |
| 4 | MP0000749_muscle_degeneration | 3.76977529 |
| 5 | MP0004036_abnormal_muscle_relaxation | 3.63897588 |
| 6 | MP0003646_muscle_fatigue | 3.59203103 |
| 7 | MP0004145_abnormal_muscle_electrophysio | 3.57920872 |
| 8 | MP0004215_abnormal_myocardial_fiber | 3.57390556 |
| 9 | MP0005330_cardiomyopathy | 2.92646049 |
| 10 | MP0003137_abnormal_impulse_conducting | 2.68730074 |
| 11 | MP0003950_abnormal_plasma_membrane | 2.68289695 |
| 12 | MP0005620_abnormal_muscle_contractility | 2.60473576 |
| 13 | MP0002972_abnormal_cardiac_muscle | 2.56854859 |
| 14 | MP0004087_abnormal_muscle_fiber | 2.43656376 |
| 15 | MP0002106_abnormal_muscle_physiology | 2.30148600 |
| 16 | MP0008775_abnormal_heart_ventricle | 2.24032129 |
| 17 | MP0000747_muscle_weakness | 2.23943491 |
| 18 | MP0004130_abnormal_muscle_cell | 2.23448835 |
| 19 | MP0004484_altered_response_of | 2.08746907 |
| 20 | MP0005369_muscle_phenotype | 2.01276723 |
| 21 | MP0004085_abnormal_heartbeat | 1.93088180 |
| 22 | MP0000920_abnormal_myelination | 1.87861708 |
| 23 | MP0000759_abnormal_skeletal_muscle | 1.86222091 |
| 24 | MP0000750_abnormal_muscle_regeneration | 1.82825805 |
| 25 | MP0010630_abnormal_cardiac_muscle | 1.74546870 |
| 26 | MP0002269_muscular_atrophy | 1.73101978 |
| 27 | MP0005385_cardiovascular_system_phenoty | 1.70484113 |
| 28 | MP0001544_abnormal_cardiovascular_syste | 1.70484113 |
| 29 | MP0006138_congestive_heart_failure | 1.69064176 |
| 30 | MP0004043_abnormal_pH_regulation | 1.67792988 |
| 31 | MP0003828_pulmonary_edema | 1.41940680 |
| 32 | MP0004270_analgesia | 1.32721277 |
| 33 | MP0003941_abnormal_skin_development | 1.30404053 |
| 34 | MP0003880_abnormal_central_pattern | 1.30171477 |
| 35 | MP0003136_yellow_coat_color | 1.29395940 |
| 36 | MP0002108_abnormal_muscle_morphology | 1.27643555 |
| 37 | MP0002127_abnormal_cardiovascular_syste | 1.24548834 |
| 38 | MP0004233_abnormal_muscle_weight | 1.22036905 |
| 39 | MP0005171_absent_coat_pigmentation | 1.21767442 |
| 40 | MP0003221_abnormal_cardiomyocyte_apopto | 1.16926554 |
| 41 | MP0010030_abnormal_orbit_morphology | 1.14986912 |
| 42 | MP0001486_abnormal_startle_reflex | 1.14927434 |
| 43 | MP0000566_synostosis | 1.14705660 |
| 44 | MP0002234_abnormal_pharynx_morphology | 1.13086356 |
| 45 | MP0003195_calcinosis | 1.11094564 |
| 46 | MP0005451_abnormal_body_composition | 1.10478919 |
| 47 | MP0009780_abnormal_chondrocyte_physiolo | 1.10171920 |
| 48 | MP0000372_irregular_coat_pigmentation | 1.10132135 |
| 49 | MP0006276_abnormal_autonomic_nervous | 1.08751235 |
| 50 | MP0002332_abnormal_exercise_endurance | 1.07698965 |
| 51 | MP0002102_abnormal_ear_morphology | 1.07232048 |
| 52 | MP0001984_abnormal_olfaction | 1.05996497 |
| 53 | MP0006036_abnormal_mitochondrial_physio | 1.03987768 |
| 54 | MP0005666_abnormal_adipose_tissue | 1.03744773 |
| 55 | MP0000778_abnormal_nervous_system | 1.02113651 |
| 56 | MP0002822_catalepsy | 1.00609586 |
| 57 | MP0001299_abnormal_eye_distance/ | 1.00414675 |
| 58 | MP0005409_darkened_coat_color | 0.98224970 |
| 59 | MP0001485_abnormal_pinna_reflex | 0.96387852 |
| 60 | MP0004142_abnormal_muscle_tone | 0.96189790 |
| 61 | MP0001529_abnormal_vocalization | 0.95381432 |
| 62 | MP0005623_abnormal_meninges_morphology | 0.95056907 |
| 63 | MP0005551_abnormal_eye_electrophysiolog | 0.94293131 |
| 64 | MP0004147_increased_porphyrin_level | 0.92688648 |
| 65 | MP0003690_abnormal_glial_cell | 0.91316312 |
| 66 | MP0000383_abnormal_hair_follicle | 0.89966063 |
| 67 | MP0005266_abnormal_metabolism | 0.89210967 |
| 68 | MP0000762_abnormal_tongue_morphology | 0.87714101 |
| 69 | MP0000230_abnormal_systemic_arterial | 0.86013369 |
| 70 | MP0004510_myositis | 0.85898999 |
| 71 | MP0003755_abnormal_palate_morphology | 0.85739049 |
| 72 | MP0004185_abnormal_adipocyte_glucose | 0.85674979 |
| 73 | MP0002272_abnormal_nervous_system | 0.85339242 |
| 74 | MP0002638_abnormal_pupillary_reflex | 0.85325793 |
| 75 | MP0002734_abnormal_mechanical_nocicepti | 0.85197585 |
| 76 | MP0003937_abnormal_limbs/digits/tail_de | 0.84728196 |
| 77 | MP0000579_abnormal_nail_morphology | 0.84727802 |
| 78 | MP0000534_abnormal_ureter_morphology | 0.84428239 |
| 79 | MP0004272_abnormal_basement_membrane | 0.84353222 |
| 80 | MP0005375_adipose_tissue_phenotype | 0.81285313 |
| 81 | MP0000733_abnormal_muscle_development | 0.79775468 |
| 82 | MP0004742_abnormal_vestibular_system | 0.79675871 |
| 83 | MP0002233_abnormal_nose_morphology | 0.77599696 |
| 84 | MP0004885_abnormal_endolymph | 0.77475217 |
| 85 | MP0009384_cardiac_valve_regurgitation | 0.76697878 |
| 86 | MP0010678_abnormal_skin_adnexa | 0.74448594 |
| 87 | MP0003634_abnormal_glial_cell | 0.73187717 |
| 88 | MP0006072_abnormal_retinal_apoptosis | 0.72954788 |
| 89 | MP0004134_abnormal_chest_morphology | 0.72048410 |
| 90 | MP0008789_abnormal_olfactory_epithelium | 0.70367235 |
| 91 | MP0005423_abnormal_somatic_nervous | 0.69720558 |
| 92 | MP0004381_abnormal_hair_follicle | 0.68402143 |
| 93 | MP0004924_abnormal_behavior | 0.67432317 |
| 94 | MP0005386_behavior/neurological_phenoty | 0.67432317 |
| 95 | MP0005165_increased_susceptibility_to | 0.67349875 |
| 96 | MP0009250_abnormal_appendicular_skeleto | 0.66748920 |
| 97 | MP0003385_abnormal_body_wall | 0.66415760 |
| 98 | MP0000003_abnormal_adipose_tissue | 0.66016451 |
| 99 | MP0008569_lethality_at_weaning | 0.65846736 |
| 100 | MP0000462_abnormal_digestive_system | 0.65289191 |
| 101 | MP0000266_abnormal_heart_morphology | 0.65287652 |
| 102 | MP0000049_abnormal_middle_ear | 0.65072497 |
| 103 | MP0002229_neurodegeneration | 0.64360087 |
| 104 | MP0003567_abnormal_fetal_cardiomyocyte | 0.64331829 |
| 105 | MP0005670_abnormal_white_adipose | 0.62605632 |
| 106 | MP0005187_abnormal_penis_morphology | 0.62415176 |
| 107 | MP0002067_abnormal_sensory_capabilities | 0.62386859 |
| 108 | MP0000427_abnormal_hair_cycle | 0.62344753 |
| 109 | MP0001440_abnormal_grooming_behavior | 0.62154751 |
| 110 | MP0003122_maternal_imprinting | 0.61039551 |
| 111 | MP0000013_abnormal_adipose_tissue | 0.60566862 |
| 112 | MP0005248_abnormal_Harderian_gland | 0.59948136 |
| 113 | MP0001346_abnormal_lacrimal_gland | 0.59005265 |
| 114 | MP0005275_abnormal_skin_tensile | 0.58979462 |
| 115 | MP0001905_abnormal_dopamine_level | 0.58312170 |
| 116 | MP0002184_abnormal_innervation | 0.58169681 |
| 117 | MP0002064_seizures | 0.56974126 |
| 118 | MP0001661_extended_life_span | 0.56009217 |
| 119 | MP0003890_abnormal_embryonic-extraembry | 0.55736128 |
| 120 | MP0000647_abnormal_sebaceous_gland | 0.55512103 |
| 121 | MP0002971_abnormal_brown_adipose | 0.55008999 |
| 122 | MP0002938_white_spotting | 0.54517100 |
| 123 | MP0008438_abnormal_cutaneous_collagen | 0.54495978 |
| 124 | MP0002114_abnormal_axial_skeleton | 0.54112847 |
| 125 | MP0005253_abnormal_eye_physiology | 0.53947062 |
| 126 | MP0002752_abnormal_somatic_nervous | 0.53600314 |
| 127 | MP0010368_abnormal_lymphatic_system | 0.53101404 |
| 128 | MP0003935_abnormal_craniofacial_develop | 0.51906998 |
| 129 | MP0004133_heterotaxia | 0.51612629 |
| 130 | MP0001293_anophthalmia | 0.51307450 |
| 131 | MP0002177_abnormal_outer_ear | 0.50946021 |
| 132 | MP0009046_muscle_twitch | 0.50690041 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Muscle hypertrophy of the lower extremities (HP:0008968) | 6.21137336 |
| 2 | Sudden death (HP:0001699) | 6.15998011 |
| 3 | Calf muscle hypertrophy (HP:0008981) | 6.11989702 |
| 4 | Exercise-induced myalgia (HP:0003738) | 6.01062869 |
| 5 | Exercise-induced muscle cramps (HP:0003710) | 5.18357437 |
| 6 | Muscle fiber splitting (HP:0003555) | 5.14980187 |
| 7 | Ventricular tachycardia (HP:0004756) | 5.14711038 |
| 8 | Abnormality of the calf musculature (HP:0001430) | 4.99119372 |
| 9 | Hyporeflexia of lower limbs (HP:0002600) | 4.91427571 |
| 10 | Atrial fibrillation (HP:0005110) | 4.77859561 |
| 11 | Primary atrial arrhythmia (HP:0001692) | 4.38922079 |
| 12 | Supraventricular tachycardia (HP:0004755) | 4.16737557 |
| 13 | Muscle fiber inclusion bodies (HP:0100299) | 4.13868841 |
| 14 | Supraventricular arrhythmia (HP:0005115) | 4.06345463 |
| 15 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 4.04868123 |
| 16 | Difficulty running (HP:0009046) | 3.89717234 |
| 17 | EMG: myopathic abnormalities (HP:0003458) | 3.87058805 |
| 18 | Myoglobinuria (HP:0002913) | 3.80300871 |
| 19 | Right ventricular cardiomyopathy (HP:0011663) | 3.75405738 |
| 20 | Syncope (HP:0001279) | 3.75297465 |
| 21 | Prolonged QT interval (HP:0001657) | 3.75260295 |
| 22 | Abnormality of the left ventricular outflow tract (HP:0011103) | 3.73179917 |
| 23 | Subaortic stenosis (HP:0001682) | 3.73179917 |
| 24 | Lipoatrophy (HP:0100578) | 3.70217829 |
| 25 | Nemaline bodies (HP:0003798) | 3.66248003 |
| 26 | Ulnar deviation of the wrist (HP:0003049) | 3.53183091 |
| 27 | Dilated cardiomyopathy (HP:0001644) | 3.45351511 |
| 28 | Calcaneovalgus deformity (HP:0001848) | 3.36477701 |
| 29 | Type 1 muscle fiber predominance (HP:0003803) | 3.32913665 |
| 30 | Absent phalangeal crease (HP:0006109) | 3.21532290 |
| 31 | Deformed tarsal bones (HP:0008119) | 3.09715158 |
| 32 | Ventricular arrhythmia (HP:0004308) | 3.02838447 |
| 33 | Frequent falls (HP:0002359) | 2.99464880 |
| 34 | Myotonia (HP:0002486) | 2.85935286 |
| 35 | Bundle branch block (HP:0011710) | 2.77759192 |
| 36 | Neck muscle weakness (HP:0000467) | 2.75043463 |
| 37 | Increased connective tissue (HP:0009025) | 2.73944967 |
| 38 | Abnormal finger flexion creases (HP:0006143) | 2.73626640 |
| 39 | Palpitations (HP:0001962) | 2.69890208 |
| 40 | Muscle stiffness (HP:0003552) | 2.66039999 |
| 41 | Abnormal EKG (HP:0003115) | 2.62617141 |
| 42 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 2.61407867 |
| 43 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 2.61407867 |
| 44 | Increased variability in muscle fiber diameter (HP:0003557) | 2.59979961 |
| 45 | Pheochromocytoma (HP:0002666) | 2.59337646 |
| 46 | Rhabdomyolysis (HP:0003201) | 2.53908654 |
| 47 | EMG: neuropathic changes (HP:0003445) | 2.53752878 |
| 48 | Left ventricular hypertrophy (HP:0001712) | 2.52652086 |
| 49 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.48420302 |
| 50 | Gowers sign (HP:0003391) | 2.47083879 |
| 51 | Ventricular fibrillation (HP:0001663) | 2.46227630 |
| 52 | Round ear (HP:0100830) | 2.45990434 |
| 53 | Hip contracture (HP:0003273) | 2.45774892 |
| 54 | Acute necrotizing encephalopathy (HP:0006965) | 2.44591994 |
| 55 | Asymmetric septal hypertrophy (HP:0001670) | 2.42007881 |
| 56 | Malignant hyperthermia (HP:0002047) | 2.40986032 |
| 57 | Heart block (HP:0012722) | 2.39062585 |
| 58 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.33315199 |
| 59 | Slender build (HP:0001533) | 2.32879044 |
| 60 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.32220832 |
| 61 | Hypoplastic ischia (HP:0003175) | 2.28189793 |
| 62 | Abnormal atrioventricular conduction (HP:0005150) | 2.25314455 |
| 63 | Spinal rigidity (HP:0003306) | 2.19710726 |
| 64 | Neuroendocrine neoplasm (HP:0100634) | 2.19679086 |
| 65 | Fetal akinesia sequence (HP:0001989) | 2.16864135 |
| 66 | Rimmed vacuoles (HP:0003805) | 2.16848427 |
| 67 | Abnormality of the foot musculature (HP:0001436) | 2.15306848 |
| 68 | Scapular winging (HP:0003691) | 2.12601730 |
| 69 | Foot dorsiflexor weakness (HP:0009027) | 2.12442872 |
| 70 | Proximal amyotrophy (HP:0007126) | 2.12367758 |
| 71 | Ketoacidosis (HP:0001993) | 2.11546618 |
| 72 | Progressive macrocephaly (HP:0004481) | 2.11393249 |
| 73 | Distal arthrogryposis (HP:0005684) | 2.11372400 |
| 74 | Increased serum pyruvate (HP:0003542) | 2.10739125 |
| 75 | Abnormality of glycolysis (HP:0004366) | 2.10739125 |
| 76 | Acute encephalopathy (HP:0006846) | 2.09821817 |
| 77 | Palmoplantar keratoderma (HP:0000982) | 2.08414280 |
| 78 | Hepatic necrosis (HP:0002605) | 2.07922411 |
| 79 | Abnormality of the ischium (HP:0003174) | 2.05667234 |
| 80 | Central scotoma (HP:0000603) | 2.03794345 |
| 81 | Muscular dystrophy (HP:0003560) | 2.01972060 |
| 82 | Hypoplasia of the iris (HP:0007676) | 2.01236296 |
| 83 | Limited hip movement (HP:0008800) | 2.00593312 |
| 84 | Limb-girdle muscle atrophy (HP:0003797) | 1.99544292 |
| 85 | Distal lower limb muscle weakness (HP:0009053) | 1.99164375 |
| 86 | Fatigable weakness (HP:0003473) | 1.99092968 |
| 87 | Abnormality of the neuromuscular junction (HP:0003398) | 1.99092968 |
| 88 | Atrioventricular block (HP:0001678) | 1.95893629 |
| 89 | Abnormality of the shoulder girdle musculature (HP:0001435) | 1.95033214 |
| 90 | Hypoplastic left heart (HP:0004383) | 1.95009335 |
| 91 | Hyperkalemia (HP:0002153) | 1.92226368 |
| 92 | Steppage gait (HP:0003376) | 1.91539351 |
| 93 | Limb-girdle muscle weakness (HP:0003325) | 1.91342040 |
| 94 | Hepatocellular necrosis (HP:0001404) | 1.87779622 |
| 95 | Weak cry (HP:0001612) | 1.87360480 |
| 96 | Mitochondrial inheritance (HP:0001427) | 1.87010962 |
| 97 | Abnormality of the hip-girdle musculature (HP:0001445) | 1.86606953 |
| 98 | Abnormality of the musculature of the pelvis (HP:0001469) | 1.86606953 |
| 99 | Generalized muscle weakness (HP:0003324) | 1.86028888 |
| 100 | Long clavicles (HP:0000890) | 1.85737286 |
| 101 | Parakeratosis (HP:0001036) | 1.83455719 |
| 102 | Areflexia of lower limbs (HP:0002522) | 1.80667543 |
| 103 | Distal lower limb amyotrophy (HP:0008944) | 1.80194916 |
| 104 | Shoulder girdle muscle weakness (HP:0003547) | 1.78559879 |
| 105 | Abnormality of the calcaneus (HP:0008364) | 1.78027649 |
| 106 | Waddling gait (HP:0002515) | 1.77023573 |
| 107 | Metabolic alkalosis (HP:0200114) | 1.76859357 |
| 108 | Cerebral edema (HP:0002181) | 1.75422104 |
| 109 | Double outlet right ventricle (HP:0001719) | 1.73896387 |
| 110 | Congenital malformation of the right heart (HP:0011723) | 1.73896387 |
| 111 | Increased circulating renin level (HP:0000848) | 1.72816651 |
| 112 | Myopathic facies (HP:0002058) | 1.72623657 |
| 113 | Methylmalonic acidemia (HP:0002912) | 1.72524620 |
| 114 | Abnormality of the corticospinal tract (HP:0002492) | 1.72358641 |
| 115 | Abnormality of fatty-acid metabolism (HP:0004359) | 1.72206989 |
| 116 | Hypoglycemic coma (HP:0001325) | 1.71685014 |
| 117 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 1.71629333 |
| 118 | Onion bulb formation (HP:0003383) | 1.68089179 |
| 119 | Difficulty climbing stairs (HP:0003551) | 1.67682004 |
| 120 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 1.66874985 |
| 121 | Popliteal pterygium (HP:0009756) | 1.65670090 |
| 122 | Bradycardia (HP:0001662) | 1.65568745 |
| 123 | Lower limb amyotrophy (HP:0007210) | 1.64767653 |
| 124 | Abnormality of dicarboxylic acid metabolism (HP:0010995) | 1.63239373 |
| 125 | Dicarboxylic aciduria (HP:0003215) | 1.63239373 |
| 126 | Conjunctival hamartoma (HP:0100780) | 1.61940367 |
| 127 | Large for gestational age (HP:0001520) | 1.60948891 |
| 128 | Delayed gross motor development (HP:0002194) | 1.60571256 |
| 129 | Broad metatarsal (HP:0001783) | 1.59923438 |
| 130 | Hypoplastic heart (HP:0001961) | 1.59655737 |
| 131 | Respiratory insufficiency due to muscle weakness (HP:0002747) | 1.59222022 |
| 132 | Increased CSF lactate (HP:0002490) | 1.58738440 |
| 133 | Broad-based gait (HP:0002136) | 1.47442045 |
| 134 | Hyperventilation (HP:0002883) | 1.47297430 |
| 135 | Bulbar palsy (HP:0001283) | 1.47292088 |
| 136 | Pelvic girdle muscle weakness (HP:0003749) | 1.45409347 |
| 137 | Ulnar deviation of finger (HP:0009465) | 1.40830457 |
| 138 | Oligomenorrhea (HP:0000876) | 1.39528710 |
| 139 | Facial diplegia (HP:0001349) | 1.38667289 |
| 140 | Metatarsus adductus (HP:0001840) | 1.35615411 |
| 141 | Type 2 muscle fiber atrophy (HP:0003554) | 1.35418214 |
| 142 | Exercise intolerance (HP:0003546) | 1.28746436 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | OBSCN | 4.88491867 |
| 2 | STK39 | 4.08118662 |
| 3 | PHKG2 | 3.56905891 |
| 4 | PHKG1 | 3.56905891 |
| 5 | TTN | 3.21195956 |
| 6 | OXSR1 | 2.71574554 |
| 7 | WNK4 | 2.65211875 |
| 8 | DMPK | 2.52379965 |
| 9 | MUSK | 2.30644129 |
| 10 | PIK3CA | 2.28943243 |
| 11 | PKN1 | 2.15206029 |
| 12 | INSRR | 2.10499073 |
| 13 | EPHB1 | 2.01418767 |
| 14 | MYLK | 1.96219404 |
| 15 | LMTK2 | 1.94512805 |
| 16 | ERBB3 | 1.74070489 |
| 17 | WNK1 | 1.71912903 |
| 18 | MAP3K4 | 1.66667057 |
| 19 | PDK4 | 1.63691996 |
| 20 | PDK3 | 1.63691996 |
| 21 | CASK | 1.62414050 |
| 22 | FRK | 1.51931613 |
| 23 | BCR | 1.46478621 |
| 24 | CAMK2D | 1.38944927 |
| 25 | TNIK | 1.37352404 |
| 26 | FGFR2 | 1.33221975 |
| 27 | PAK3 | 1.31757558 |
| 28 | PINK1 | 1.31526237 |
| 29 | GRK7 | 1.29054017 |
| 30 | MARK1 | 1.27946718 |
| 31 | MAP2K4 | 1.22423252 |
| 32 | ICK | 1.15257035 |
| 33 | TIE1 | 1.14531508 |
| 34 | ZAK | 1.11854082 |
| 35 | PDK2 | 1.11808745 |
| 36 | TRIM28 | 1.11641341 |
| 37 | MAP2K7 | 1.07510834 |
| 38 | MAP3K7 | 1.06424364 |
| 39 | PRKD1 | 1.06371841 |
| 40 | STK24 | 1.06141559 |
| 41 | SGK223 | 1.03172795 |
| 42 | SGK494 | 1.03172795 |
| 43 | MET | 1.00885185 |
| 44 | BCKDK | 1.00816573 |
| 45 | ROCK2 | 0.98391582 |
| 46 | PIK3CG | 0.97506496 |
| 47 | UHMK1 | 0.96172162 |
| 48 | CCNB1 | 0.95761259 |
| 49 | CAMK2A | 0.94228744 |
| 50 | LIMK1 | 0.93300084 |
| 51 | TRPM7 | 0.93155681 |
| 52 | NEK1 | 0.92709416 |
| 53 | MAP4K2 | 0.92304001 |
| 54 | ROCK1 | 0.90464499 |
| 55 | LATS1 | 0.90218772 |
| 56 | PRKCE | 0.89946796 |
| 57 | AKT3 | 0.87687564 |
| 58 | WNK3 | 0.87407980 |
| 59 | PRKAA2 | 0.86753415 |
| 60 | PNCK | 0.85968749 |
| 61 | MAPKAPK3 | 0.84618821 |
| 62 | MAPK12 | 0.83946140 |
| 63 | CAMK1G | 0.83499025 |
| 64 | NEK6 | 0.78672517 |
| 65 | CSNK1A1L | 0.77723113 |
| 66 | MAPKAPK5 | 0.76645879 |
| 67 | CAMK2B | 0.75857589 |
| 68 | PRPF4B | 0.74357985 |
| 69 | MAPK13 | 0.71792231 |
| 70 | CAMK2G | 0.71791859 |
| 71 | SGK2 | 0.68389527 |
| 72 | BMPR1B | 0.67076438 |
| 73 | GRK1 | 0.66305836 |
| 74 | MAP3K6 | 0.65943534 |
| 75 | NME1 | 0.65174834 |
| 76 | MARK2 | 0.64477168 |
| 77 | ACVR1B | 0.64356250 |
| 78 | CDC42BPA | 0.64083318 |
| 79 | IRAK2 | 0.61619747 |
| 80 | CAMK1 | 0.61011602 |
| 81 | PRKAA1 | 0.60844892 |
| 82 | NTRK2 | 0.60280767 |
| 83 | PRKACB | 0.59575309 |
| 84 | PRKG1 | 0.56844957 |
| 85 | PLK2 | 0.55364509 |
| 86 | NEK9 | 0.55359966 |
| 87 | EPHA4 | 0.55353841 |
| 88 | PRKACA | 0.54262210 |
| 89 | PAK6 | 0.53662472 |
| 90 | DYRK1B | 0.53477272 |
| 91 | CSNK1G3 | 0.52203977 |
| 92 | IRAK1 | 0.51957987 |
| 93 | KSR1 | 0.51468928 |
| 94 | SGK1 | 0.50826951 |
| 95 | CAMK4 | 0.50449580 |
| 96 | ILK | 0.50329921 |
| 97 | FER | 0.48903833 |
| 98 | CDK19 | 0.48754958 |
| 99 | CSNK1G1 | 0.48591299 |
| 100 | MAPK15 | 0.48556386 |
| 101 | SIK1 | 0.47484344 |
| 102 | DYRK2 | 0.46541228 |
| 103 | CAMK1D | 0.44104700 |
| 104 | ADRBK1 | 0.43721712 |
| 105 | CSNK1G2 | 0.43514039 |
| 106 | LATS2 | 0.41992190 |
| 107 | PDPK1 | 0.41668883 |
| 108 | PDGFRB | 0.40449308 |
| 109 | PRKCQ | 0.40426708 |
| 110 | TGFBR1 | 0.40395391 |
| 111 | DYRK3 | 0.40026520 |
| 112 | MKNK2 | 0.39851803 |
| 113 | AKT2 | 0.39727087 |
| 114 | CDK5 | 0.39214492 |
| 115 | NUAK1 | 0.38547228 |
| 116 | SGK3 | 0.37149763 |
| 117 | MAP2K1 | 0.37035302 |
| 118 | ERBB4 | 0.36928733 |
| 119 | EPHB2 | 0.36422122 |
| 120 | EPHA3 | 0.35727683 |
| 121 | STK11 | 0.35664386 |
| 122 | FGFR1 | 0.35344148 |
| 123 | STK38L | 0.33706104 |
| 124 | PRKCG | 0.33696052 |
| 125 | MAPK7 | 0.33418584 |
| 126 | MAP3K12 | 0.33309345 |
| 127 | TYRO3 | 0.31029126 |
| 128 | GSK3A | 0.30729575 |
| 129 | CSNK1D | 0.30467179 |
| 130 | PRKCH | 0.30412292 |
| 131 | PRKACG | 0.30074023 |
| 132 | DYRK1A | 0.29348148 |
| 133 | RPS6KA3 | 0.29057661 |
| 134 | STK3 | 0.26866105 |
| 135 | FLT3 | 0.24589377 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 3.37655285 |
| 2 | Fatty acid elongation_Homo sapiens_hsa00062 | 3.28860466 |
| 3 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 2.91113836 |
| 4 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 2.90986539 |
| 5 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 2.90842090 |
| 6 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 2.85991694 |
| 7 | Propanoate metabolism_Homo sapiens_hsa00640 | 2.77551579 |
| 8 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.61569173 |
| 9 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 2.37362261 |
| 10 | Parkinsons disease_Homo sapiens_hsa05012 | 2.36510679 |
| 11 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.13287343 |
| 12 | Fatty acid metabolism_Homo sapiens_hsa01212 | 2.10466671 |
| 13 | Alzheimers disease_Homo sapiens_hsa05010 | 2.05249378 |
| 14 | Butanoate metabolism_Homo sapiens_hsa00650 | 2.01976130 |
| 15 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.97261925 |
| 16 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.87682381 |
| 17 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.87541996 |
| 18 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.62289874 |
| 19 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.55973810 |
| 20 | * Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.49430568 |
| 21 | Huntingtons disease_Homo sapiens_hsa05016 | 1.30260477 |
| 22 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.29342277 |
| 23 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.24646751 |
| 24 | Nitrogen metabolism_Homo sapiens_hsa00910 | 1.19694681 |
| 25 | Axon guidance_Homo sapiens_hsa04360 | 1.14421382 |
| 26 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.11088653 |
| 27 | Ether lipid metabolism_Homo sapiens_hsa00565 | 1.10617634 |
| 28 | Tight junction_Homo sapiens_hsa04530 | 1.07940819 |
| 29 | Phototransduction_Homo sapiens_hsa04744 | 1.05895724 |
| 30 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.04481090 |
| 31 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 1.03959795 |
| 32 | Carbon metabolism_Homo sapiens_hsa01200 | 1.03257223 |
| 33 | Nicotine addiction_Homo sapiens_hsa05033 | 1.02987499 |
| 34 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.01350690 |
| 35 | Hippo signaling pathway_Homo sapiens_hsa04390 | 1.00446240 |
| 36 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.99208075 |
| 37 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.98641591 |
| 38 | Adherens junction_Homo sapiens_hsa04520 | 0.98562094 |
| 39 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.97979775 |
| 40 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.95811748 |
| 41 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.92122815 |
| 42 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.88432814 |
| 43 | Circadian entrainment_Homo sapiens_hsa04713 | 0.86627610 |
| 44 | Renin secretion_Homo sapiens_hsa04924 | 0.85198421 |
| 45 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.84471970 |
| 46 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.84013409 |
| 47 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.82107740 |
| 48 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.80957328 |
| 49 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.80569988 |
| 50 | Serotonergic synapse_Homo sapiens_hsa04726 | 0.77906599 |
| 51 | * Dopaminergic synapse_Homo sapiens_hsa04728 | 0.77408251 |
| 52 | Glutamatergic synapse_Homo sapiens_hsa04724 | 0.77341038 |
| 53 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.76729297 |
| 54 | GABAergic synapse_Homo sapiens_hsa04727 | 0.74104324 |
| 55 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 0.73967851 |
| 56 | Insulin secretion_Homo sapiens_hsa04911 | 0.73606951 |
| 57 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.72518613 |
| 58 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.71410147 |
| 59 | Lysine degradation_Homo sapiens_hsa00310 | 0.71272581 |
| 60 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.71259541 |
| 61 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.70817990 |
| 62 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 0.70776131 |
| 63 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.69872898 |
| 64 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.69666029 |
| 65 | Taste transduction_Homo sapiens_hsa04742 | 0.69521216 |
| 66 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.69328714 |
| 67 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.68792788 |
| 68 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.68784984 |
| 69 | Peroxisome_Homo sapiens_hsa04146 | 0.68553077 |
| 70 | Viral myocarditis_Homo sapiens_hsa05416 | 0.68477767 |
| 71 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.67928794 |
| 72 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.67305396 |
| 73 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.66692097 |
| 74 | Focal adhesion_Homo sapiens_hsa04510 | 0.66115703 |
| 75 | Morphine addiction_Homo sapiens_hsa05032 | 0.65277844 |
| 76 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.64844102 |
| 77 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.63151630 |
| 78 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.60368033 |
| 79 | Insulin resistance_Homo sapiens_hsa04931 | 0.60356426 |
| 80 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.59517944 |
| 81 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.59314527 |
| 82 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.58679904 |
| 83 | Ubiquitin mediated proteolysis_Homo sapiens_hsa04120 | 0.57946421 |
| 84 | Wnt signaling pathway_Homo sapiens_hsa04310 | 0.57407447 |
| 85 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.57278349 |
| 86 | Olfactory transduction_Homo sapiens_hsa04740 | 0.55981683 |
| 87 | Salivary secretion_Homo sapiens_hsa04970 | 0.53941301 |
| 88 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.53824496 |
| 89 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.53171403 |
| 90 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.50948642 |
| 91 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.50875258 |
| 92 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.50738080 |
| 93 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.49971874 |
| 94 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.49574463 |
| 95 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.49384384 |
| 96 | * AMPK signaling pathway_Homo sapiens_hsa04152 | 0.47408775 |
| 97 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.45910010 |
| 98 | Long-term depression_Homo sapiens_hsa04730 | 0.45472044 |
| 99 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.42683343 |
| 100 | Melanoma_Homo sapiens_hsa05218 | 0.42565029 |
| 101 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.42410221 |
| 102 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.41584315 |
| 103 | Gap junction_Homo sapiens_hsa04540 | 0.40137868 |
| 104 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.39764984 |
| 105 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.39121688 |
| 106 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.38975144 |
| 107 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.38368938 |
| 108 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.38052151 |
| 109 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.35812051 |
| 110 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.35516446 |
| 111 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.35245957 |
| 112 | Histidine metabolism_Homo sapiens_hsa00340 | 0.34915118 |
| 113 | Circadian rhythm_Homo sapiens_hsa04710 | 0.33885491 |
| 114 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 0.33563569 |
| 115 | Cocaine addiction_Homo sapiens_hsa05030 | 0.31992223 |
| 116 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.31964631 |
| 117 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.31757318 |
| 118 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.31306730 |
| 119 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.31306482 |
| 120 | Metabolic pathways_Homo sapiens_hsa01100 | 0.30735313 |
| 121 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.30454037 |
| 122 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.29630505 |
| 123 | Melanogenesis_Homo sapiens_hsa04916 | 0.27793823 |

